COMMUNIQUÉS West-GlobeNewswire

Xcellon Biologics Acquires GMP Manufacturing Facility from NextCure, Becoming an End-to-End CRDMO for Next-Generation Bioconjugates and Complex Biologics
10/08/2026
Acquisition of the GMP biologics manufacturing facility expands Xcellon’s integrated capabilities from discovery through clinical supply and strengthens U.S. biomanufacturing BELTSVILLE, Md., Aug. 10, 2026 (GLOBE [...]
PerfectServe Ushers in New Era of AI in Voice with Intelligent Answering powered by ConnectiveIQ
10/08/2026
AI answering service draws on 30 years of clinical workflow expertise and features the first application of Sloane, PerfectServe’s virtual AI agent MIAMI, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Most answering services can [...]
Artelo Announces Enrollment of First Patient in a Phase 2 Clinical Trial Evaluating ART27.13 for Treatment of Glaucoma
10/08/2026
Investigator-led study funded by Glaucoma UK and the HSC R&D Division expands ART27.13’s clinical potential into ophthalmology Initial DREAM Study Results Anticipated in Q4 2026 SOLANA BEACH, Calif., Aug. 10, 2026 ( [...]
CMS Proposed 2027 Medicare Policy Continues Recognition of the FDA’s Section 351 Biologic Pathway
10/08/2026
Applied Biologics believes rigorous scientific development and regulatory standards are essential to advancing innovation in chronic wound care SCOTTSDALE, Ariz., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Applied Biologics, a [...]
AIM ImmunoTech Reports Second Quarter 2026 Financial Results and Highlights Significant Operational Execution Advancing Ampligen® Toward Planned Phase 3 Development in Pancreatic Cancer
10/08/2026
Completed Enrollment and Ampligen Dosing in Metastatic Pancreatic Cancer Phase 2 Trial, Positioning Company for Key Clinical Milestones Through Early 2027 Pancreatic Cancer Remains Strategic Priority as AIM Advances [...]
Kura Oncology Announces Publication in Blood Highlighting Ziftomenib’s Differentiated Binding Profile and Preclinical Activity
10/08/2026
– Publication details the discovery and preclinical characterization of ziftomenib, including its potency, selectivity, and mechanism of action – – Findings demonstrate differentiated menin binding and activity against [...]
TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss Second Quarter 2026 Financial Results on August 14, 2026
10/08/2026
FREDERICK, Md., Aug. 10, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions today announced it will report results for the second [...]
Capricor Therapeutics to Report Second Quarter 2026 Financial Results and Provide Recent Corporate Update on August 13
10/08/2026
– Company to Host Conference Call on August 13, 2026, at 4:30 p.m. ET – SAN DIEGO, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and [...]
Wave Life Sciences Announces Completion of Redomiciliation to Delaware
10/08/2026
CAMBRIDGE, Mass., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences, Inc. (NASDAQ: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health (“ [...]
Baird Medical and Alpmed Enter Strategic Partnership to Advance Irreversible Electroporation (IRE) Technology Globally
10/08/2026
Agreement combines Baird Medical's clinical, regulatory, and global commercialization expertise with Alpmed's leadership in IRE technology Collaboration will advance technology development, global regulatory approvals, [...]
Autonomix Medical Congratulates Co-Founder & Chief Medical Officer Dr. Robert Schwartz on Receiving Prestigious 2026 Cardiovascular Tech Forum Lifetime Achievement Award
10/08/2026
Recognition honors one of the medical technology industry's most influential innovators, whose career has helped shape modern cardiovascular care THE WOODLANDS, TX, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, [...]
Vystar Completes Acquisition of R3ALM Financial Ecosystem, Targets $120 Million Tokenized Equity Launch
10/08/2026
■ ■ ■ Consideration includes approximately 8,371 shares of Vystar Series B preferred stock Parties intend to jointly manage and develop the R3alm platform R3alm is being developed as a compliance-focused ecosystem [...]
Silo Pharma Granted European Patent Covering Novel PTSD Therapy
10/08/2026
Patent strengthens global IP protection for novel treatment approach designed to prevent stress-induced psychiatric disorders before symptoms develop SARASOTA, FLA., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Silo Pharma (Nasdaq [...]
Hemp Hop THCa Dispensary Extends Pickup and Charlotte Same Day Delivery Hours to 11 PM Daily
10/08/2026
CHARLOTTE, N.C., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Hemp Hop, a THCa dispensary founded in Charlotte in 2018, has extended both dispensary pickup and Charlotte same day THCa delivery hours from 10 PM to 11 PM every day. [...]
Nanox.AI Optimizes Medical Imaging AI Application Framework for Intel Core Ultra Processors with OpenVINO
10/08/2026
On-premise medical imaging AI framework uses Intel Core Ultra processors and Intel ’s OpenVINO toolkit to accelerate edge inference within healthcare environments PETACH TIKVA, Israel – August 10 – Nanox AI Ltd. , a [...]
Life Biosciences Appoints Stephen Webster to Board of Directors
10/08/2026
Former Spark Therapeutics Chief Financial Officer brings deep biotech finance, commercialization, and governance expertise BOSTON, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Life Biosciences (“Life Bio”), a clinical-stage [...]
Alpha Tau Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE)
10/08/2026
JERUSALEM, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) (“Alpha Tau” or the “Company”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT ® , today announced its [...]
Replimune Announces Pricing of $150 Million Underwritten Offering
10/08/2026
BOSTON, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL) (“Replimune”), a commercial-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced the [...]
Rani Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference
10/08/2026
SAN JOSE, Calif., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on oral delivery of biologics, today announced that the company’s [...]

Pages